Company: PTPI
Filing Date: 2025-03-14
Form Type: PRER14A
Source: 0001104659-25-024012
Chunk: 74

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-14
Form: PRER14A
Chunk 74
---
ation to vote in favor of this proposal, you should be aware that our directors and executive officers and existing stockholders
may have interests that may be different from, or in addition to, the interests of other of our stockholders. In particular, ICIG,
which beneficially owns more than 5% of our voting securities, and its affiliate IMF, and 3i, LP (“3i”), Five Narrow Lane
LP (“Five Narrow”) and Alto Opportunity Master Fund, SPC-Segregated Master Portfolio B, together with its affiliates (“Alto”),
beneficially own more than 5% of our voting securities and hold shares of the Series A Preferred Stock, Series Warrants, Warrants
and/or Pre-Funded Warrants. ICIG, IMF, 3i, Five Narrow and Alto may be unable exercise all of the Warrants and convert their Series A
Preferred stock if this proposal is not approved by our stockholders.

Because it is anticipated
that our directors and executive officers will be granted additional equity awards under our Plan, or another plan we adopt in the future,
they may be deemed to have an indirect interest in the Share Increase Amendment. Additionally, certain of our directors and officers may
be deemed to have an interest in the Share Increase Amendment due to the Option Waivers, in which such directors and officers agreed to
not exercise certain options held by them until the Share Increase Amendment is approved.

Required Vote

The affirmative vote of the
holders of majority of the votes cast by stockholders present by virtual attendance or represented by proxy at the Special Meeting and
entitled to vote on the Share Increase Proposal is required to approve the Share Increase Proposal. “ABSTAIN” votes will
have no effect on the Share Increase Proposal. Because the Share Increase Proposal is not considered a routine matter, your bank, broker,
trustee or other nominee, as the case may be, will not be able to vote your shares without your instruction with respect to the Share
Increase Proposal. As a result, the failure to instruct your bank, broker, trustee or other nominee as to how to vote on the Share Increase
Proposal will result in a broker non-vote, which will have no effect on the results of this vote.

<div align='center'>THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE “FOR” THE SHARE INCREASE
PROPOSAL, AND PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN FAVOR THEREOF
UNLESS A